StonvexLoading…
StonvexStonvexStonvexCore line items from SABS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Q3 2024 2024-09-30 | Q2 2024 2024-06-30 |
|---|---|---|---|---|
Revenue | $0.00 | $1.32M | $1.21M | $1.21M |
Operating Income | $-48.95M | $-42.91M | $-32.90M | $-21.59M |
Net Income | $13.27M | $-34.11M | $-22.71M | $-7.34M |
EPS (Diluted) | $-0.79 | $-3.68 | $-2.45 | $-1.34 |
Total Assets | $172.81M | $44.20M | $53.80M | $61.89M |
Total Liabilities | $21.32M | $18.23M | $16.89M | $15.77M |
Cash & Equivalents | $10.50M | $8.90M | $9.17M | $17.24M |
Free Cash Flow OCF − CapEx | $-45.71M | $-34.63M | $-25.04M | $-18.65M |
Shares Outstanding | 47.61M | 9.29M | 9.23M | 9.23M |